AAOS: Stem Cell Tx for Knee OA Costs About $5,000 Per Injection

Share this content:
AAOS: Stem Cell Tx for Knee OA Costs About $5,000 Per Injection
AAOS: Stem Cell Tx for Knee OA Costs About $5,000 Per Injection

TUESDAY, March 6, 2018 (HealthDay News) -- Despite low-level evidence, stem cell therapy for knee osteoarthritis is expanding, with centers reporting high clinical efficacy and direct-to-consumer mean cost exceeding $5,000 for each therapy, according to a study presented at the annual meeting of the American Academy of Orthopaedic Surgeons, held from March 6 to 10 in New Orleans.

Nicolas Santiago Piuzzi, M.D., from the Cleveland Clinic, and colleagues conducted a prospective cross-sectional study and queried 273 U.S. centers that offered direct-to-consumer stem cell therapies for musculoskeletal conditions. The centers were contacted using a simulated 57-year-old male patient with knee osteoarthritis.

The researchers found that the mean cost of therapy was $5,156 (range, $1,150 to $12,000) for the 65 centers that provided pricing information for a same-day stem cell unilateral knee injection. Fourteen and 10 of the centers charged less than $3,000 and more than $8,000 per injection. The mean marketed clinical efficacy was 82.2 percent (range, 55 to 100 percent) for the 36 centers that provided information on clinical efficacy. Ten of the 36 clinics claimed efficacy of 90 to 100 percent; 15 claimed efficacy of 80 to 90 percent, 10 claimed efficacy of 70 to 80 percent, and one claimed clinical efficacy of 55 percent or greater.

"The use of stem cell therapies for the treatment of various musculoskeletal conditions, especially knee osteoarthritis, is rapidly expanding, despite there being only low-level evidence to support its use," the authors write.

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »